Los Angeles Capital Management
RAPT

Los Angeles Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Los Angeles Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,123
Closed -$226K – 1438
2025
Q1 		$226K Sell
23,123
-4,377
-16% -$43K ﹤0.01% 977
2024
Q4 		$348K Buy
27,500
+2,320
+9% +$29.5K ﹤0.01% 898
2024
Q3 		$405K Buy
25,180
+14,607
+138% +$295K ﹤0.01% 920
2024
Q2 		$258K Buy
10,573
+4,211
+66% +$195K ﹤0.01% 1063
2024
Q1 		$457K Buy
6,362
+5,190
+443% +$722K ﹤0.01% 899
2023
Q4 		$233K Buy
+1,172
New +$145K ﹤0.01% 1072
2023
Q3 		– Sell
-3,594
Closed -$538K – 1216
2023
Q2 		$538K Sell
3,594
-7,828
-69% -$1.22M ﹤0.01% 831
2023
Q1 		$1.68M Sell
11,422
-3,716
-25% -$752K 0.01% 539
2022
Q4 		$2.4M Buy
15,138
+13,626
+901% +$2.18M 0.01% 474
2022
Q3 		$291K Buy
+1,512
New +$286K ﹤0.01% 1076
2022
Q1 		– Sell
-1,322
Closed -$388K – 1480
2021
Q4 		$388K Hold
1,322
– – ﹤0.01% 1126
2021
Q3 		$328K Sell
1,322
-972
-42% -$257K ﹤0.01% 1267
2021
Q2 		$583K Buy
2,294
+99
+5% +$18.5K ﹤0.01% 1109
2021
Q1 		$390K Buy
+2,195
New +$362K ﹤0.01% 1329

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Los Angeles Capital Management's RAPT Position: Q2 2025 in Review

Los Angeles Capital Management sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 23,123 shares — an estimated $226K sold.

Los Angeles Capital Management first reported a position in RAPT in Q1 2021 and held it in 14 quarters. The position peaked at $2.4M in Q4 2022. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Los Angeles Capital Management reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 23,123 RAPT Therapeutics shares in Q2 2025, an estimated $226K.
  • Los Angeles Capital Management first reported a position in RAPT Therapeutics in Q1 2021 and held it in 14 quarters.
  • Los Angeles Capital Management's RAPT Therapeutics position peaked at $2.4M in Q4 2022.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Los Angeles Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.